Partnering Business Model

Amarantus Therapeutics believes that it has far more viable development opportunities than any single company could adequately exploit. As such, Amarantus intends to partner therapy development with leading academic institutions, research institutes, hospitals, clinics, small to large scale biotechnology, pharmaceutical and device companies to achieve maximum value creation for its high-value, multi-purposed drug candidates.

Amarantus Therapeutics is interested in partnering opportunities for its drug candidates that will allow development of adjunct therapies that will address diseases caused by poorly served biological pathways. We intend to generate revenues through collecting up-front and royalty payments as our therapeutic candidates advance through pre-clinical and clinical development, and royalties upon commercialization.